Ciaffoni Joseph 4
4 · COLLEGIUM PHARMACEUTICAL, INC · Filed Dec 22, 2023
Insider Transaction Report
Form 4
Ciaffoni Joseph
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2023-12-21$21.34/sh+4,357$92,978→ 279,357 total - Sale
Common Stock
2023-12-21$30.38/sh−4,357$132,377→ 275,000 total - Exercise/Conversion
Stock Option (Right to Purchase)
2023-12-21−4,357→ 16,875 totalExercise: $21.34Exp: 2030-02-05→ Common Stock (4,357 underlying)
Footnotes (3)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2023.
- [F2]The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.13 to $30.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]Twenty-five percent (25%) of the option vests and becomes exercisable on February 10, 2021, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the following three-year period, subject to the Reporting Person's continued service with the Issuer.